Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-05-02 @ 1:59 AM
Study NCT ID:
NCT01788020
Status:
COMPLETED
Last Update Posted:
2024-05-13
First Post:
2013-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Sponsor:
University of Ulm
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ECWM-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |